Compositions and methods for regulating phagocytosis and ICAM-1 expression

Details for Australian Patent Application No. 2003204412 (hide)

Owner Johnson & Johnson Consumer Companies, Inc

Inventors Eisinger, Magdalena; Miri, Seiberg; Shapiro, Stanley S

Agent Baldwin Shelston Waters

Pub. Number AU-A-2003204412

Parent 17220

Filing date 28 May 2003

Wipo publication date 3 July 2003

International Classifications

A61K 038/08 Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 009/127 Medicinal preparations characterised by special physical form - Liposomes

A61K 007/00

A61K 038/17 Medicinal preparations containing peptides - from animals

A61K 038/48 Medicinal preparations containing peptides

Event Publications

19 June 2003 Complete Application Filed

3 July 2003 Application Open to Public Inspection

  Published as AU-A-2003204412

24 August 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003204413-Method and apparatus for centering a glass flow control tube

2003204411-a -hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors